BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 26722517)

  • 1. Expression of somatostatin receptors (SSTR1-SSTR5) in meningiomas and its clinicopathological significance.
    Silva CB; Ongaratti BR; Trott G; Haag T; Ferreira NP; Leães CG; Pereira-Lima JF; Oliveira Mda C
    Int J Clin Exp Pathol; 2015; 8(10):13185-92. PubMed ID: 26722517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of somatostatin receptor mRNA in human meningiomas and their implication in in vitro antiproliferative activity.
    Arena S; Barbieri F; Thellung S; Pirani P; Corsaro A; Villa V; Dadati P; Dorcaratto A; Lapertosa G; Ravetti JL; Spaziante R; Schettini G; Florio T
    J Neurooncol; 2004 Jan; 66(1-2):155-66. PubMed ID: 15015781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of merlin, NDRG2, ERBB2, and c-MYC in meningiomas: relationship with tumor grade and recurrence.
    Ongaratti BR; Silva CB; Trott G; Haag T; Leães CG; Ferreira NP; Oliveira MC; Pereira-Lima JF
    Braz J Med Biol Res; 2016; 49(4):e5125. PubMed ID: 27007654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abundant immunohistochemical expression of dopamine D2 receptor and p53 protein in meningiomas: follow-up, relation to gender, age, tumor grade, and recurrence.
    Trott G; Pereira-Lima JF; Leães CG; Ferreira NP; Barbosa-Coutinho LM; Oliveira MC
    Braz J Med Biol Res; 2015 May; 48(5):415-9. PubMed ID: 25742638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival.
    Ke HL; Ke RH; Li B; Wang XH; Wang YN; Wang XQ
    Acta Neurochir (Wien); 2013 Jan; 155(1):165-71. PubMed ID: 23053286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of EGFR expression in de novo and progressed atypical and anaplastic meningiomas: an immunohistochemical and fluorescence in situ hybridization pilot study.
    Caltabiano R; Barbagallo GM; Castaing M; Cassenti A; Senetta R; Cassoni P; Albanese V; Lanzafame S
    J Neurosurg Sci; 2013 Jun; 57(2):139-51. PubMed ID: 23486338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of c-Myc, neurofibromatosis Type 2, somatostatin receptor 2 and erb-B2 in human meningiomas: relation to grades or histotypes.
    Durand A; Champier J; Jouvet A; Labrousse F; Honnorat J; Guyotat J; Fèvre-Montange M
    Clin Neuropathol; 2008; 27(5):334-45. PubMed ID: 18808065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
    Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
    APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue thioredoxin-interacting protein expression predicted recurrence in patients with meningiomas.
    Cai Z; Zhang C; Zou Y; Lu C; Hu H; Qian J; Jiang L; Hu G
    Int J Clin Oncol; 2017 Aug; 22(4):660-666. PubMed ID: 28243945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sstr2A immunohistochemical expression in human meningiomas: is there a correlation with the histological grade, proliferation or microvessel density?
    Barresi V; Alafaci C; Salpietro F; Tuccari G
    Oncol Rep; 2008 Sep; 20(3):485-92. PubMed ID: 18695896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological variables, immunophenotype, chromosome 1p36 loss and tumour recurrence of 247 meningiomas grade I and II.
    Ruiz J; Martínez A; Hernández S; Zimman H; Ferrer M; Fernández C; Sáez M; López-Asenjo JA; Sanz-Ortega J
    Histol Histopathol; 2010 Mar; 25(3):341-9. PubMed ID: 20054806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteopontin expression is a valuable marker for prediction of short-term recurrence in WHO grade I benign meningiomas.
    Tseng KY; Chung MH; Sytwu HK; Lee HM; Chen KY; Chang C; Lin CK; Yen CH; Chen JH; Lin GJ; Ma HI; Yeh YS; Ju DT; Liu MY; Hueng DY
    J Neurooncol; 2010 Nov; 100(2):217-23. PubMed ID: 20428925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin Receptors in Human Meningiomas-Clinicopathological Aspects.
    Tollefsen SE; Jarmund AH; Ytterhus B; Salvesen Ø; Mjønes P; Torp SH
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas.
    Barresi V; Cerasoli S; Vitarelli E; Tuccari G
    Acta Neuropathol; 2007 Aug; 114(2):147-56. PubMed ID: 17594108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin Receptor 2 Expression in Canine Meningioma.
    Foiani G; Guelfi G; Chiaradia E; Mancini F; Trivelli C; Vitellozzi G; Lepri E; Mandara MT
    J Comp Pathol; 2019 Jan; 166():59-68. PubMed ID: 30691608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of STMN1 is associated with the prognosis of meningioma patients.
    Wang H; Li W; Wang G; Zhang S; Bie L
    Neurosci Lett; 2017 Jul; 654():1-5. PubMed ID: 28625575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.
    Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H
    Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of UbcH10 expression and its association with recurrence of meningiomas.
    Jiang L; Wang T; Bao Y; Qian J; Wu XJ; Hu GH; Lu YC
    J Surg Oncol; 2012 Sep; 106(3):327-31. PubMed ID: 22095464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Necrosis is a consistent factor to recurrence of meningiomas: should it be a stand-alone grading criterion for grade II meningioma?
    Góes P; Santos BFO; Suzuki FS; Salles D; Stávale JN; Cavalheiro S; de Paiva Neto MA
    J Neurooncol; 2018 Apr; 137(2):331-336. PubMed ID: 29270884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microvascularization and expression of VEGF and its receptors in recurring meningiomas: pathobiological data in favor of anti-angiogenic therapy approaches.
    Preusser M; Hassler M; Birner P; Rudas M; Acker T; Plate KH; Widhalm G; Knosp E; Breitschopf H; Berger J; Marosi C
    Clin Neuropathol; 2012; 31(5):352-60. PubMed ID: 22541785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.